Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Active Ulcerative Colitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07463183
What this trial is testing

Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)

Who this might be right for
Colitis UlcerativeUlcerative Colitis
Merck Sharp & Dohme LLC 100
Large-scale testing (Phase 3)Study completedNCT01008410
What this trial is testing

Efficacy and Safety of Budesonide Foam for Participants With Active Mild to Moderate Ulcerative Proctitis or Proctosigmoiditis

Who this might be right for
ProctitisProctosigmoiditis
Bausch Health Americas, Inc. 265
Large-scale testing (Phase 3)Study completedNCT01100112
What this trial is testing

(CB-01-02/06) Oral Budesonide-Multi-Matrix System (MMX) 9mg Extended Release Tablets

Who this might be right for
Colitis, Ulcerative
Bausch Health Americas, Inc. 61
Testing effectiveness (Phase 2)Study completedNCT01482884
What this trial is testing

Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
AstraZeneca 147
Testing effectiveness (Phase 2)Study completedNCT00808977
What this trial is testing

A Phase II Study to Explore the Safety and Activity of Dersalazine in Patients With Mild to Moderate Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Palau Pharma S.L.U. 80
Testing effectiveness (Phase 2)Study completedNCT00063414
What this trial is testing

ISIS 2302-CS22, A 6-Week, Active-Controlled Clinical Study to Evaluate the Effectiveness of Alicaforsen (ISIS 2302) in Patients With Mild to Moderate Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Ionis Pharmaceuticals, Inc.
Early research (Phase 1)UnknownNCT05743010
What this trial is testing

A Phase 1b Study to Evaluate APL-1401 in Patients With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Jiangsu Yahong Meditech Co., Ltd aka Asieris 36
Testing effectiveness (Phase 2)WithdrawnNCT04096573
What this trial is testing

Efficacy and Safety of LC51-0255 in Subjects With Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
LG Chem
Testing effectiveness (Phase 2)Study completedNCT00659802
What this trial is testing

Phase II Study of HMPL-004 in Patients With Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Hutchison Medipharma Limited 224
Testing effectiveness (Phase 2)Study completedNCT04102852
What this trial is testing

Lactobacillus Rhamnosus GG (ATCC 53103) in Mild-moderately Active UC Patients

Who this might be right for
Ulcerative Colitis Chronic MildUlcerative Colitis Chronic Moderate
San Giovanni Addolorata Hospital 76
Testing effectiveness (Phase 2)Looking for participantsNCT06764615
What this trial is testing

A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)

Who this might be right for
Crohn's DiseaseUlcerative Colitis
Takeda 192
Large-scale testing (Phase 3)Active Not RecruitingNCT06052059
What this trial is testing

Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001)

Who this might be right for
Ulcerative Colitis
Merck Sharp & Dohme LLC 1,020
Testing effectiveness (Phase 2)Study completedNCT03648541
What this trial is testing

BI 655130 Long-term Treatment in Patients With moderate-to Severe Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Boehringer Ingelheim 79
Large-scale testing (Phase 3)Looking for participantsNCT07071519
What this trial is testing

Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
AbbVie 120
Not applicableLooking for participantsNCT06073873
What this trial is testing

A Post-Marketing Surveillance Study to Assess Safety of Ozanimod in Patients With Moderate to Severe Active UC in Korea

Who this might be right for
Ulcerative Colitis
Bristol-Myers Squibb 3,000
Testing effectiveness (Phase 2)Ended earlyNCT04677179
What this trial is testing

LY3471851 in Adult Participants With Moderately to Severely Active Ulcerative Colitis (UC)

Who this might be right for
Colitis, Ulcerative
Nektar Therapeutics 81
Early research (Phase 1)Looking for participantsNCT05666960
What this trial is testing

R-3750 in Patients With Mild to Moderate Ulcerative Colitis

Who this might be right for
Ulcerative Colitis Chronic MildUlcerative Colitis Chronic ModerateUlcerative Colitis Chronic+1 more
Rise Therapeutics LLC 36
Testing effectiveness (Phase 2)Study completedNCT03093259
What this trial is testing

ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Abivax S.A. 32
Testing effectiveness (Phase 2)Study completedNCT02536404
What this trial is testing

Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Arena Pharmaceuticals 118
Testing effectiveness (Phase 2)Looking for participantsNCT05287126
What this trial is testing

Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Pfizer 36
Next Page